GSK-LSD1   Click here for help

GtoPdb Ligand ID: 8241

Compound class: Synthetic organic
Comment: GSK-LSD1 is a potent, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1; gene symbol KDM1A) [1]. The compound was developed by GlaxoSmithKline and has been made available for inclusion in the portfolio of compounds held by the Structural Genomics Consortium (SGC) in their Epigenetics Probes Collection.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 24.06
Molecular weight 216.16
XLogP 1.9
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N1CCC(CC1)NC1CC1c1ccccc1
Isomeric SMILES N1CCC(CC1)N[C@@H]1C[C@H]1c1ccccc1
InChI InChI=1S/C14H20N2/c1-2-4-11(5-3-1)13-10-14(13)16-12-6-8-15-9-7-12/h1-5,12-16H,6-10H2/t13-,14+/m0/s1
InChI Key BASFYRLYJAZPPL-UONOGXRCSA-N
Bioactivity Comments
Bioactivity data may have been generated using the dihydrochloride salt.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
lysine demethylase 1A Primary target of this compound Hs Inhibitor Inhibition 7.8 pIC50 - 1
pIC50 7.8 (IC50 1.6x10-8 M) [1]